Upload Avatar (500 x 500)
Junwei Han
hanjunwei@ems.hrbmu.edu.cn
Chinese, English
Heilongjiang
Harbin Medical University
College of Bioinformatics Science and Technology
  • Selected as a high-level talent in Heilongjiang Province
  • Star Alliance Young Scholar
  • Harbin Science and Technology Innovation Talent
  • Independent Principal Investigator
  • National Natural Science Foundation of China Communication Review Expert
  • Heilongjiang Province Science and Technology Award Second Prize (2020): Research on Disease Similarity Algorithm Based on Multi-Association Data Fusion
  • Heilongjiang Higher Education Society Excellent Higher Education Research Achievement Second Prize (2017)
  • Harbin Medical University Teaching Achievement Award Second Prize (2019)
Bioinformatics
Artificial Intelligence Medicine
Deep Learning
Biological Software Development
  • iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell–cell crosstalk network, Yuqi Sheng, Jiashuo Wu, Xiangmei Li, Jiayue Qiu, Ji Li, Qinyu Ge, Liang Cheng, Junwei Han, 2023
  • Anovel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy, Li, Xiangmei; He, Yalan; Wu, Jiashuo; Qiu, Jiayue; Ji Li; Wang, Qian; Jiang, Ying; Junwei Han, 2022
  • CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancer, Sheng, Yuqi; Jiang, Ying; Yang, Yang; Li, Xiangmei; Qiu, Jiayue; Wu, Jiashuo; Cheng, Liang; Han, Junwei, 2021
  • psSubpathway: a software package for flexible identification of phenotype-specific subpathways in cancer progression, Han, Junwei; Han, Xudong; Kong, Qingfei; Cheng, Liang, 2020
  • SubtypeDrug: a software package for prioritization of candidate cancer subtype-specific drugs, Han, Xudong; Kong, Qingfei; Liu, Chonghui; Cheng, Liang; Han, Junwei, 2021
  • DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk network, Wu, Jiashuo; Li, Xiangmei; Wang, Qian; Han, Junwei, 2022
  • DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing, Jiashuo Wu, Ji Li, Yalan He, Junling Huang, Xilong Zhao, Bingyue Pan, Yahui Wang, Liang Cheng, Junwei Han, 2023
  • DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19, Yinchun Su, Jiashuo Wu, Xiangmei Li, Ji Li, Xilong Zhao, Bingyue Pan, Junling Huang, Qingfei Kong, Junwei Han, 2023
  • PathwayTMB: A pathway-based tumor mutational burden analysis method for predicting the clinical outcome of cancer immunotherapy, Xiangmei Li, Yalan He, Ying Jiang, Bingyue Pan, Jiashuo Wu, Xilong Zhao, Junling Huang, Qian Wang, Liang Cheng, Junwei Han, 2023
  • Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy, Qiu, Jiayue; Li, Xiangmei; He, Yalan; Wang, Qian; Li, Ji; Wu, Jiashuo; Jiang, Ying; Han, Junwei, 2022
  • Pan-cancer analysis reveals sex-specific signatures in the tumor microenvironment, Han, Junwei; Yang, Yang; Li, Xiangmei; Wu, Jiashuo; Sheng, Yuqi; Qiu, Jiayue; Wang, Qian; Li, Ji; He, Yalan; Cheng, Liang; Zhang, Yan, 2022
  • Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities, Di, Jieyi; Zheng, Baotong; Kong, Qingfei; Jiang, Ying; Liu, Siyao; Yang, Yang; Han, Xudong; Sheng, Yuqi; Zhang, Yunpeng; Cheng, Liang; Han, Junwei, 2019
  • A pathway-based mutation signature to predict the clinical outcomes and response to CTLA-4 inhibitors in melanoma, Qian Wang, Xiangmei Li, Jiayue Qiu, Yalan He, Jiashuo Wu, Ji Li, Wei Liu, Junwei Han, 2023
  • PCLassoLog: A protein complex-based, group Lasso-logistic model for cancer classification and risk protein complex discovery, Wang, Wei; Yuan, Haiyan; Han, Junwei; Liu, Wei, 2022
  • Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic Pathway Signatures, Li, Ji; Qiu, Jiayue; Han, Junwei; Li, Xiangmei; Jiang, Ying, 2022
  • Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures, Li, Ji; Wu, Jiashuo; Han, Junwei, 2022
  • Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme, Han, Xudong; Wang, Donghua; Zhao, Ping; Liu, Chonghui; Hao, Yue; Chang, Lulu; Zhao, Jiarui; Zhao, Wei; Mu, Lili; Wang, Jinghua; Li, Hulun; Kong, Qingfei; Han, Junwei, 2020
  • Development and Validation of a Three-Gene Prognostic Signature Based on Tumor Microenvironment for Gastric Cancer, Wang, Qian; Li, Xiangmei; Wang, Yahui; Qiu Jiayue; Wu, Jiashuo; He, Yalan Li, Ji; Kong, Qingfei; Han, Junwei; Jiang, Ying, 2022
  • Inference of patient-specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer, Han, Junwei; Liu, Siyao; Jiang, Ying; Xu, Chaohan; Zheng, Baotong; Jiang, Minghao; Yang, Haixiu; Su, Fei; Li, Chunquan; Zhang, Yunpeng, 2018
  • Integrative Pathway Analysis of Genes and Metabolites Reveals Metabolism Abnormal Subpathway Regions and Modules in Esophageal Squamous Cell Carcinoma, Li, Chunquan; Wang, Qiuyu; Ma, Jiquan; Shi, Shengshu; Chen, Xin; Yang, Haixiu; Han, Junwei, 2017
  • Identification of Cancer Dysfunctional Subpathways by Integrating DNA Methylation, Copy Number Variation, and Gene-Expression Data, Liu Siyao; Zheng Baotong; Sheng Yuqi; Kong Qingfei; Jiang Ying; Yang Yang; Han Xudong; Cheng Liang; Zhang Yunpeng; Han Junwei, 2019
  • Identification of Somatic Mutation-Driven Immune Cells by Integrating Genomic and Transcriptome Data, Jiang, Ying; Zheng, Baotong; Yang, Yang; Li, Xiangmei; Han, Junwei, 2021
  • Identifying disease related sub-pathways for analysis of genome-wide association studies, Li, Chunquan; Han, Junwei; Shang, Desi; Li, Jing; Wang, Yan; Wang, YingYing; Zhang, Yunpeng; Yao, Qianlan; Zhang, Chunlong; Li, Kongning; Li, Xia, 2012
  • Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways, Li, Chunquan; Han, Junwei; Yao, Qianlan; Zou, Chendan; Xu, Yanjun; Zhang, Chunlong; Shang, Desi; Zhou, Lingyun; Zou, Chaoxia; Sun, Zeguo; Li, Jing; Zhang, Yunpeng; Yang, Haixiu; Gao, Xu; Li, Xia, 2013
  • Computational Methods for Identifying Similar Diseases, Cheng, Liang; Zhao, Hengqiang; Wang, Pingping; Zhou, Wenyang; Luo, Meng; Li, Tianxin; Han, Junwei; Liu, Shulin; Jiang, Qinghua, 2019
  • LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method, Han, Junwei; Liu, Siyao; Sun, Zeguo; Zhang, Yunpeng; Zhang, Fan; Zhang, Chunlong; Shang, Desi; Yang, Haixiu; Su, Fei; Xu, Yanjun; Li, Chunquan; Ren, Huan; Li, Xia, 2017
  • A novel dysregulated pathway-identification analysis based on global influence of within-pathway effects and crosstalk between pathways, Han, Junwei; Li, Chunquan; Yang, Haixiu; Xu, Yanjun; Zhang, Chunlong; Ma, Jiquan; Shi, Xinrui; Liu, Wei; Shang, Desi; Yao, Qianlan; Zhang, Yunpeng; Su, Fei; Feng, Li; Li, Xia, 2015
  • ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis, Han, Junwei; Shi, Xinrui; Zhang, Yunpeng; Xu, Yanjun; Jiang, Ying; Zhang, Chunlong; Feng, Li; Yang, Haixiu; Shang, Desi; Sun, Zeguo; Su, Fei; Li, Chunquan; Li, Xia, 2015
Bioinformatics Ai Medicine Deep Learning Software Development Cancer Research Pathway Analysis Genomics Data Integration Machine Learning Computational Biology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.